Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Weiss

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology GroupP A Bunn, J Crowley, K Kelly, et al.
Anti-Cancer Drugs|October 1, 1994
Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812)T J O'Rourke, G R Weiss, P New, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1987
New anticancer agentsG R Weiss, C L Arteaga, T D Brown, et al.
Journal of the National Cancer Institute|July 3, 1991
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group studyM Zalupski, B Metch, S Balcerzak, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
New anticancer agentsT D Brown, K A Havlin, J M Koeller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1989
A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanomaJ P Dutcher, S Creekmore, G R Weiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
A phase I and pharmacokinetic study of tallimustine [PNU 152241 (FCE 24517)] in patients with advanced cancerG R Weiss, I Poggesi, M Rocchetti, et al.
Cancer|September 26, 1997
Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology GroupP N Grozea, J J Crowley, V A Canfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomasK Antman, J Crowley, S P Balcerzak, et al.
Anti-Cancer Drugs|April 1, 1995
Deoxyspergualin: phase I clinical, immunologic and pharmacokinetic studyK A Havlin, J G Kuhn, J Koeller, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology GroupP A Bunn, J Crowley, K Kelly, et al.
Anti-Cancer Drugs|October 1, 1994
Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812)T J O'Rourke, G R Weiss, P New, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1987
New anticancer agentsG R Weiss, C L Arteaga, T D Brown, et al.
Journal of the National Cancer Institute|July 3, 1991
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group studyM Zalupski, B Metch, S Balcerzak, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
New anticancer agentsT D Brown, K A Havlin, J M Koeller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1989
A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanomaJ P Dutcher, S Creekmore, G R Weiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
A phase I and pharmacokinetic study of tallimustine [PNU 152241 (FCE 24517)] in patients with advanced cancerG R Weiss, I Poggesi, M Rocchetti, et al.
Cancer|September 26, 1997
Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology GroupP N Grozea, J J Crowley, V A Canfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomasK Antman, J Crowley, S P Balcerzak, et al.
Anti-Cancer Drugs|April 1, 1995
Deoxyspergualin: phase I clinical, immunologic and pharmacokinetic studyK A Havlin, J G Kuhn, J Koeller, et al.
Pageof 10